Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis.
D000900:Anti-Bacterial Agents / Q000096:biosynthesis*; D007933:Leucomycins / Q000096:biosynthesis / Q000302:isolation & purification; D009682:Magnetic Resonance Spectroscopy; D008826:Microbial Sensitivity Tests; D008970:Molecular Weight; D013056:Spectrophotometry, Ultraviolet; D013302:Streptomyces / Q000378:metabolism*; D013329:Structure-Activity Relationship; D015645:Tylosin / Q000031:analogs & derivatives*
D000900:Anti-Bacterial Agents; D007933:Leucomycins; C039124:chimeramycin A; C039125:chimeramycin B; D015645:Tylosin